DV
Dividend Vision

JBIO — Jade Biosciences, Inc.

Jade Biosciences, Inc. (JBIO)

Its deepest 1-year drawdown was 44.2%.

JBIO is an equity fund focused on the biosciences sector that commenced operations in June 2021. The fund lacks publicly available information on its underlying holdings, distribution frequency, expense ratio, and current assets under management, making detailed characteristic assessment unavailable. This fund appeals to investors interested in biosciences exposure, though potential investors should independently verify current fund specifications and performance data given the limited public information provided.

JBIO key facts

Asset type
Stock
Asset class
Equity
Inception date
06/30/2021
Last close
$24.71
Market cap
$1,571,491,456
Average volume
1478400.0
Last dividend
$0.0686
Ex-dividend date
04/29/2025
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.11